Congress mandates healthcare price transparency—but enforcement depends on HHS capacity.

What it does

This bill requires hospitals, insurers, clinical laboratories, imaging providers, and ambulatory surgical centers to publicly disclose their prices for medical services in machine-readable formats, including gross charges, discounted cash prices, and negotiated rates with insurance plans. Patients gain access to transparent pricing information to shop for care; providers face civil penalties ($300–$35 per bed per day for hospitals, up to $10 million for insurers) for non-compliance, with enforcement beginning in 2026–2027.

Why we flagged it

The bill's core mechanism is a regulatory mandate requiring disclosure of pricing data across multiple healthcare sectors. It is not a subsidy, tax carve-out, or immunity grant—it is a transparency and accountability measure that restricts provider discretion to hide prices.

What the text implies

• Disclosure of negotiated rates and algorithms may expose proprietary contracting strategies and competitive pricing information, potentially enabling reverse-engineering of negotiation leverage by competitors or consolidating market power among larger health systems that can absorb compliance costs.
• The requirement to disclose de-identified maximum and minimum negotiated charges may inadvertently reveal market concentration or pricing disparities by geography or payer, creating pressure for price convergence that could reduce negotiating leverage for smaller payers.
• Compliance burden falls disproportionately on smaller hospitals and independent providers with limited IT infrastructure; larger health systems with existing data systems may gain competitive advantage, potentially accelerating consolidation.
• The bill does not restrict balance billing or out-of-network charges; transparency alone does not guarantee affordability for uninsured or underinsured patients who cannot negotiate rates.
• Enforcement relies on civil monetary penalties and corrective action plans; no private right of action is created, so patients cannot sue for non-compliance—enforcement depends entirely on HHS/CMS capacity and political will.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Ordinary citizens gain concrete tools to compare prices before receiving care, enabling informed shopping and potentially reducing out-of-pocket costs through cash-pay discounts. Providers face compliance costs and penalties, but these are accountability measures that correct a market failure (information asymmetry) rather than restrictions on citizens' rights or remedies.

Who stands to gain

• Health IT vendors (price transparency software, data aggregation platforms)
• Price comparison and shopping platforms (e.g., healthcare cost transparency startups)
• Self-insured employers (gain access to negotiated rate data for benchmarking)
• Patients paying out-of-pocket or seeking cash discounts

Named in the bill

Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services (HHS), Hospitals (including critical access hospitals, rural emergency hospitals), Clinical diagnostic laboratories, Imaging service providers, Ambulatory surgical centers, Health insurance issuers and group health plans, Accountable Care Organizations (ACOs), Third-party payers, State insurance commissioners

Where it stands

12 cosponsors: 6 Democrats, 6 Republicans.

• Sep 26, 2025 — Introduced · Congress.gov: “Introduced in House”
• Sep 26, 2025 — Referred to House Committee on Ways and Means and House Committee on Education and Workforce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

46 lobbying clients named this bill on 51 disclosure filings across 3 quarters, Dec 2025 to Jun 2026. Those filings disclosed $23,962,490 in lobbying spend. A filing names 7 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 99% of bills with at least one filing.

John James, the sponsor, reported $224,000 in PAC receipts in the 2026 cycle. $4,500 of that came from 2 PACs tied to these lobbying clients.

• American Hospital Association — $4,470,000 on 1 filing
• Elevance Health, Inc. — $4,010,000 on 2 filings
• Pharmaceutical Care Management Association — $3,282,990 on 1 filing
• Boeing Company — $2,770,000 on 1 filing
• National Association of Children's Hospitals (n.a.c.h.) — $1,370,000 on 1 filing

Lobbying Disclosure Act filings through Jul 21, 2026. A filing shows who paid to lobby on a bill it names, not what changed.